Research ArticleOriginal Research

Modified Medical Research Council Dyspnea Scale in GOLD Classification Better Reflects Physical Activities of Daily Living

Anelise B Munari, Aline A Gulart, Karoliny dos Santos, Raysa S Venâncio, Manuela Karloh and Anamaria F Mayer
Respiratory Care January 2018, 63 (1) 77-85; DOI: https://doi.org/10.4187/respcare.05636

REFERENCES

  1. 1.↵
    Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2017. http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/.
  2. 2.↵
    1. Barnes PJ,
    2. Celli BR
    . Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33(5):1165–1185.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 Available from: http://www.goldcopd.org/.
  4. 4.↵
    1. Karloh M,
    2. Fleig Mayer A,
    3. Maurici R,
    4. Pizzichini MM,
    5. Jones PW,
    6. Pizzichini E
    . The COPD assessment test: what do we know so far?: a systematic review and meta-analysis about clinical outcomes prediction and classification of patients into GOLD stages. Chest 2016;149(2):413–425.
    OpenUrl
  5. 5.↵
    1. Zogg S,
    2. Dürr S,
    3. Miedinger D,
    4. Steveling EH,
    5. Maier S,
    6. Leuppi JD
    . Differences in classification of COPD patients into risk groups A–D: a cross-sectional study. BMC Res Notes 2014;7:562.
    OpenUrl
  6. 6.↵
    1. Demeyer H,
    2. Gimeno-Santos E,
    3. Rabinovich RA,
    4. Hornikx M,
    5. Louvaris Z,
    6. de Boer WI,
    7. et al
    . Physical activity characteristics across GOLD quadrants depend on the questionnaire used. PLoS One 2016;11(3):e0151255.
    OpenUrl
  7. 7.↵
    1. Moreira GL,
    2. Donaria L,
    3. Furlanetto KC,
    4. Paes T,
    5. Sant'Anna T,
    6. Hernandes NA,
    7. Pitta F
    . GOLD B-C-D groups or GOLD II-III-IV grades: which one better reflects the functionality of patients with chronic obstructive pulmonary disease? Chron Respir Dis 2015;12(2):102–110.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Gimeno-Santos E,
    2. Frei A,
    3. Steurer-Stey C,
    4. de Batlle J,
    5. Rabinovich RA,
    6. Raste Y,
    7. et al
    . Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax 2014;69(8):731–739.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Vestbo J,
    2. Hurd SS,
    3. Agustí AG,
    4. Jones PW,
    5. Vogelmeier C,
    6. Anzueto A,
    7. et al
    . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347–365.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Demeyer H,
    2. Burtin C,
    3. Van Remoortel H,
    4. Hornikx M,
    5. Langer D,
    6. Decramer M,
    7. et al
    . Standardizing the analysis of physical activity in patients with COPD following a pulmonary rehabilitation program. Chest 2014;146(2):318–327.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al
    . Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Pereira CA,
    2. Sato T,
    3. Rodrigues SC
    . New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 2007;33(4):397–406.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Van Remoortel H,
    2. Raste Y,
    3. Louvaris Z,
    4. Giavedoni S,
    5. Burtin C,
    6. Langer D,
    7. et al
    . Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One 2012;7(6):e39198.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Pitta F,
    2. Troosters T,
    3. Spruit MA,
    4. Probst VS,
    5. Decramer M,
    6. Gosselink R
    . Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171(9):972–977.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Hill K,
    2. Gardiner PA,
    3. Cavalheri V,
    4. Jenkins SC,
    5. Healy GN
    . Physical activity and sedentary behaviour: applying lessons to chronic obstructive pulmonary disease. Intern Med J 2015;45(5):474–482.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Furlanetto KC,
    2. Donária L,
    3. Schneider LP,
    4. Lopes JR,
    5. Ribeiro M,
    6. Hernandes KB,
    7. et al
    . Sedentary behavior is an independent predictor of mortality in subjects with COPD. Respir Care 2017;62(5):579–587.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. van Remoortel H,
    2. Camillo CA,
    3. Langer D,
    4. Hornikx M,
    5. Demeyer H,
    6. Burtin C,
    7. et al
    . Moderate intense physical activity depends on selected metabolic equivalent of task (MET) cut-off and type of data analysis. PLoS One 2013;8(12):e84365.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Depew ZS,
    2. Novotny PJ,
    3. Benzo RP
    . How many steps are enough to avoid severe physical inactivity in patients with chronic obstructive pulmonary disease? Respirology 2012;17(6):1026–1027.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Jones PW,
    2. Nadeau G,
    3. Small M,
    4. Adamek L
    . Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations. Respir Med 2014;108(1):129–135.
    OpenUrlCrossRefPubMed
  20. 20.
    1. Price DB,
    2. Baker CL,
    3. Zou KH,
    4. Higgins VS,
    5. Bailey JT,
    6. Pike JS
    . Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification. Int J Chron Obstruct Pulmon Dis 2014;9:551–561.
    OpenUrl
  21. 21.
    1. Han J,
    2. Dai L,
    3. Zhong N,
    4. Young D
    . Breathlessness or health status in chronic obstructive pulmonary disease: the impact of different definitions. COPD 2015;12(2):115–125.
    OpenUrlCrossRef
  22. 22.
    1. Jones PW,
    2. Adamek L,
    3. Nadeau G,
    4. Banik N
    . Comparisons of health status scores with MRC grades in a primary care COPD population: implications for the new GOLD 2011 classification. Eur Respir J 2013;42(3):647–654.
    OpenUrlAbstract/FREE Full Text
  23. 23.
    1. Kim S,
    2. Oh J,
    3. Kim YI,
    4. Ban HJ,
    5. Kwon YS,
    6. Oh IJ,
    7. et al
    . Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. BMC Pulm Med 2013(Can't get issue from record);13:35.
  24. 24.↵
    1. Rieger-Reyes C,
    2. García-Tirado FJ,
    3. Rubio-Galán FJ,
    4. Marín-Trigo JM
    . Classification of chronic obstructive pulmonary disease severity according to the new Global Initiative for Chronic Obstructive Lung Disease 2011 guidelines: COPD assessment test versus modified Medical Research Council scale. Arch Bronconeumol 2014;50(4):129–134.
    OpenUrl
  25. 25.
    1. Casanova C,
    2. Marin JM,
    3. Martinez-Gonzalez C,
    4. de Lucas-Ramos P,
    5. Mir-Viladrich I,
    6. Cosio B,
    7. et al
    . New GOLD classification: longitudinal data on group assignment. Respir Res 2014;15:3.
    OpenUrlCrossRefPubMed
  26. 26.
    1. Pillai AP,
    2. Turner AM,
    3. Stockley RA
    . Global Initiative for Chronic Obstructive Lung Disease 2011 symptom/risk assessment in α1-antitrypsin deficiency. Chest 2013;144(4):1152–1162.
    OpenUrl
  27. 27.↵
    1. Han MK,
    2. Muellerova H,
    3. Curran-Everett D,
    4. Dransfield MT,
    5. Washko GR,
    6. Regan EA,
    7. et al
    . GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med 2013;1(1):43–50.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. García-Rio F,
    2. Soriano JB,
    3. Miravitlles M,
    4. Muñoz L,
    5. Duran-Tauleria E,
    6. Sánchez G,
    7. et al
    . Frequency of multi-dimensional COPD indices and relation with disease activity markers. COPD 2013;10(4):436–443.
    OpenUrlCrossRef
  29. 29.↵
    1. Barusso MS,
    2. Gianjoppe-Santos J,
    3. Basso-Vanelli RP,
    4. Regueiro EM,
    5. Panin JC,
    6. Di Lorenzo VA
    . Limitation of activities of daily living and quality of life based on COPD combined classification. Respir Care 2015;60(3):388–398.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Durheim MT,
    2. Smith PJ,
    3. Babyak MA,
    4. Mabe SK,
    5. Martinu T,
    6. Welty-Wolf KE,
    7. et al
    . Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group. Ann Am Thorac Soc 2015;12(3):349–356.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Miravitlles M,
    2. Huerta A,
    3. Fernández-Villar JA,
    4. Alcázar B,
    5. Villa G,
    6. Forné C,
    7. et al
    . Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Outcomes 2014;12:120.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Boland MR,
    2. Tsiachristas A,
    3. Kruis AL,
    4. Chavannes NH,
    5. Rutten-van Mölken MP
    . Are GOLD ABCD groups better associated with health status and costs than GOLD 1234 grades? A cross-sectional study. Prim Care Respir J 2014;23(1):30–37.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Leivseth L,
    2. Brumpton BM,
    3. Nilsen TI,
    4. Mai XM,
    5. Johnsen R,
    6. Langhammer A
    . GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway. Thorax 2013;68(10):914–921.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Casanova C,
    2. Marin JM,
    3. Martinez-Gonzalez C,
    4. de Lucas-Ramos P,
    5. Mir-Viladrich I,
    6. Cosio B,
    7. et al
    . Differential effect of modified medical research council dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD. Chest 2015;148(1):159–168.
    OpenUrl
  35. 35.
    1. Soriano JB,
    2. Lamprecht B,
    3. Ramírez AS,
    4. Martinez-Camblor P,
    5. Kaiser B,
    6. Alfageme I,
    7. et al
    . Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. Lancet Respir Med 2015;3(6):443–450.
    OpenUrl
  36. 36.
    1. Lange P,
    2. Marott JL,
    3. Vestbo J,
    4. Olsen KR,
    5. Ingebrigtsen TS,
    6. Dahl M,
    7. Nordestgaard BG
    . Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012;186(10):975–981.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    1. Agusti A,
    2. Edwards LD,
    3. Celli B,
    4. Macnee W,
    5. Calverley PM,
    6. Mullerova H,
    7. et al
    . Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J 2013;42(3):636–646.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Jones PW,
    2. Harding G,
    3. Berry P,
    4. Wiklund I,
    5. Chen WH,
    6. Kline Leidy N
    . Development and first validation of the COPD assessment test. Eur Respir J 2009;34(3):648–654.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Nishimura K,
    2. Izumi T,
    3. Tsukino M,
    4. Oga T
    . Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121(5):1434–1440.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.↵
    1. Pitta F,
    2. Takaki MY,
    3. Oliveira NH,
    4. Sant'anna TJ,
    5. Fontana AD,
    6. Kovelis D,
    7. et al
    . Relationship between pulmonary function and physical activity in daily life in patients with COPD. Respir Med 2008;102(8):1203–1207.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Hunt T,
    2. Madigan S,
    3. Williams MT,
    4. Olds TS
    . Use of time in people with chronic obstructive pulmonary disease: a systematic review. Int J Chron Obstruct Pulmon Dis 2014;9:1377–1388.
    OpenUrl
  42. 42.↵
    1. Wilmot EG,
    2. Edwardson CL,
    3. Achana FA,
    4. Davies MJ,
    5. Gorely T,
    6. Gray LJ,
    7. et al
    . Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia 2012;55(11):2895–2905.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    1. Agusti A,
    2. Hurd S,
    3. Jones P,
    4. Fabbri LM,
    5. Martinez F,
    6. Vogelmeier C,
    7. et al
    . FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts. Eur Respir J 2013;42(5):1391–1401.
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    1. Biddle SJ,
    2. Bennie JA,
    3. Bauman AE,
    4. Chau JY,
    5. Dunstan D,
    6. Owen N,
    7. et al
    . Too much sitting and all-cause mortality: is there a causal link? BMC Public Health 2016;16:635.
    OpenUrlCrossRefPubMed
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords